leisure time -WSS

leisure time

author：focus 2025-10-02 11:08:25 - browse：73

Aerial photograph of Austin, Texas — Austin, Texas has become the grounds for dueling powerful interests fighting over health care services for poor patients. Brandon Bell/Getty Images

AUSTIN, Texas — The partnership between one of the nation’s largest Catholic health systems and a local government agency focused on caring for poor patients was supposed to be mutually beneficial for everyone involved. But it didn’t quite turn out that way.

The alliance in theory meant that Travis County, home to the growing metro area of Austin, could provide more care to low-income patients cheaper than other big cities in the state. And Ascension, a not-for-profit behemoth, would get to own a brand-new teaching hospital and work with an elite new medical school at the University of Texas at Austin.

But two decades after the agency and Ascension first came together in the name of providing care for poor patients, their relationship has almost completely unraveled.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Trial using CRISPR to edit HIV out of cells disappoints

WSS

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Congress considering partial increase for doctor pay in Medicare

Medicare Advantage 2025 payments will dip, Biden administration says

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Ebola vaccine can save some who are already sick, per new study

Study gives hint on South Asians’ higher risk of cardiovascular disease

explore

leisure time

entertainment

Virginia high school admissions case could be legal follow

Pancreatic cancer is often deadly, but new discoveries are raising hope

BioMarin wins approval for gene therapy to treat hemophilia A

Congress must protect the remaining independent doctors

Walensky prepares to leave CDC — and Congress — behind

Having children helps parents live longer, especially after age 80

In Memoriam: Notable people who died in 2023

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

entertainment

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

UnitedHealth, in a surprise, takes aim at Steward’s physician group

U.K. decision on ALS drug has neurologists, advocates up in arms

Researchers test human milk's ability to repair gut microbiome

Overprescribed: High cost isn't America's only drug problem

Readout Newsletter: Amylyx, Aurinia, and IQVIA

hotspot

focus

focus

leisure time